Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Explore wealth mindset tips and strategies that can help you build wealth smartly. Start applying these techniques for success!
28,655 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
A once-sacrosanct pledge to never dump bitcoin treasury holdings is showing cracks as firms explore selling slices to...
The AI rally has expanded beyond the marquee leaders, lifting a wider group of software and cybersecurity names. Anal...
Amazon blends a sprawling logistics network with a fast-growing AI infrastructure business, signaling a rare asset-he...
XRP failed to sustain a move above $1.40 this week, opening the door to downside risk. Here are the latest ripple (xr...
As the crypto market hesitates, the critical network (pi) update advances toward a June deadline. XRP declines, and a...
London expands sanctions by applying bank-style rules to crypto exchanges and targeting the Kremlin-backed A7 network...
Hyperliquid (HYPE) enters the top 10 by market cap, surpassing Dogecoin and signaling a rare DeFi-led move in a chopp...
A fresh Wall Street call boosts Broadcom stock, signaling a potential historic buy as AI chip demand and a multi-year...
AST SpaceMobile and SpaceX surged after the launch of the largest direct-to-phone satellites, signaling a potential s...
Netflix falls on growth and valuation concerns while iHeartMedia rises on an expanded podcast partnership. The move h...
XRP sits near the $1 level, slipping 9% over the past week and 52% year over year. An analyst says the move could for...